Literature DB >> 6342127

Branhamella catarrhalis as a cause of bacteremic pneumonia.

M Malkamäki, E Honkanen, M Leinonen, P H Mäkelä.   

Abstract

A new enzyme immunoassay was used to confirm the pathogenetic role of Branhamella catarrhalis in a diabetic young man with pneumonia affecting the left lower lobe with pleural involvement. His temperature rise was only minimal, but his ESR and blood leucocyte count were elevated and one blood culture grew B. catarrhalis. The levels of branhamella antibodies of the IgG and IgA classes were high and rose during the infection.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6342127     DOI： 10.3109/inf.1983.15.issue-1.21

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN： 0036-5548


  11 in total

1.  Labile type-specific antigen of Moraxella catarrhalis.

Authors:  S J Norkus; J W Vennes
Journal:  J Clin Microbiol       Date:  1990-12       Impact factor: 5.948

Review 2.  Moraxella catarrhalis bacteremic pneumonia in adults: two cases and review of the literature.

Authors:  J Collazos; J de Miguel; R Ayarza
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-03       Impact factor: 3.267

Review 3.  Historical perspectives and identification of Neisseria and related species.

Authors:  J S Knapp
Journal:  Clin Microbiol Rev       Date:  1988-10       Impact factor: 26.132

Review 4.  [Moraxella catarrhalis: virulence and resistance mechanisms].

Authors:  W Cullmann
Journal:  Med Klin (Munich)       Date:  1997-03-15

5.  Wound infection caused by Branhamella catarrhalis.

Authors:  L D Gray; R E Van Scoy; J P Anhalt; P K Yu
Journal:  J Clin Microbiol       Date:  1989-05       Impact factor: 5.948

6.  Expression of the CopB outer membrane protein by Moraxella catarrhalis is regulated by iron and affects iron acquisition from transferrin and lactoferrin.

Authors:  C Aebi; B Stone; M Beucher; L D Cope; I Maciver; S E Thomas; G H McCracken; P F Sparling; E J Hansen
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

7.  Mapping of a protective epitope of the CopB outer membrane protein of Moraxella catarrhalis.

Authors:  C Aebi; L D Cope; J L Latimer; S E Thomas; C A Slaughter; G H McCracken; E J Hansen
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

8.  A major outer membrane protein of Moraxella catarrhalis is a target for antibodies that enhance pulmonary clearance of the pathogen in an animal model.

Authors:  M E Helminen; I Maciver; J L Latimer; L D Cope; G H McCracken; E J Hansen
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

9.  In vitro susceptibilities of isolates from patients with Branhamella catarrhalis pneumonia compared with those of colonizing strains.

Authors:  K G Sweeney; A Verghese; C A Needham
Journal:  Antimicrob Agents Chemother       Date:  1985-04       Impact factor: 5.191

10.  Incidence of Branhamella catarrhalis in the sputa of patients with chronic lung disease.

Authors:  J A Pollard; R J Wallace; D R Nash; J I Luman; R W Wilson
Journal:  Drugs       Date:  1986       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.